The Dissociation of Factor VIII by Reducing Agents, High Salt Concentration and Affinity Chromatography

Summary

Incubation of a factor Vlll-rich fraction of plasma with a high concentration of salt confirmed the production of both high (HMW) and low (LMW) molecular weight factor VIII clotting activity (FVIIIC) as determined by agarose gel filtration but with considerable overlap. The electrophoretic mobility of factor VIII related protein (FVIIIRP) detected by precipitating rabbit antiserum was not affected by this treatment and LMW FVIIIC devoid of FVIIIRP was apparently produced. At low concentration the reducing agent dithiothreitol (DTT) altered the electrophoretic mobility of FVIIIRP. At higher concentrations it altered both its mobility and antigenicity and an LMW FVIIIRP was produced. Contrary to the findings of other workers no LMW FVIIIC devoid of FVIIIRP was produced. In further studies factor Vlll-rich plasma fraction was treated with sepharose beads to which had been coupled a non-coagulation inhibitory precipitating rabbit antibody to FVIIIRP. Both FVIIIRP and FVIIIC were taken up by the beads but after elution with 1.5 M NaCl, FVIIIC of LMW and devoid of FVIIIRP was selectively removed. Antisera raised to LMW FVIIIC produced with 1.5 M NaCl either by the gel filtration or affinity chromatography methods inhibited FVIIIC and precipitated with HMW factor Vlll-rich fractions. The results were consistent with the possibility that factor VIII clotting activity and FVIIIRP exist in plasma as a non-covalently bound complex.

• References

• 1 Austen D. E. G. 1974; Factor VIII of small molecular weight and its aggregation. British Journal of Haematology 27: 89.
• 2 Austen D. E. G, Carey M, Howard M. A. 1975; Dissociation of factor VHI-related antigen into subunits. Nature 253: 55.
• 3 Bennett B, Ratnoff O. D. 1972; Changes in antihemophilic factor (AHF, factor VIII) procoagulant activity and AHF-like antigen in normal pregnancy, and following exercise and pneumoencephalography. Journal of Laboratory and Clinical Medicine 80: 256.
• 4 Bloom A. L, Giddings J. C. 1972; Factor VIII (antihaemophilic factor) in tissues detected by antibody neutralisation. British Journal of Haematology 23: 157.
• 5 Bloom A. L, Giddings J. C, Wilks C. J. 1973; Factor VIII on the vascular intima: possible importance in haemostasis and thrombosis. Nature (New Biology) 241: 271.
• 6 Bloom A. L, Peake I. R, Giddings J. C. 1973; The presence and reactions of high and lower molecular weight procoagulant factor VIII in the plasma of patients with von Willebrand’s disease after treatment: significance for a structural hypothesis for factor VIII. Thrombosis Research 3: 389.
• 7 Clarke H. G. M, Freeman T. 1968; Quantitative immunoelectrophoresis of human serum proteins. Clinical Science 35: 403.
• 8 Cooper H. A, Wagner R. H. 1974; The defect in hemophilic and von Willebrand’s disease plasmas studied by a re-combination technique. Journal of Clinical Investigation 54: 1093.
• 9 Hardisty R. M, Ingram G. I. C. 1965. Bleeding Disorders, Investigation and Management. Blackwell Scientific Publications; Oxford:
• 10 Hougie C, Sargeant R. 1973; Antigen/biological-activity ratio for factor VIII. Lancet 2: 616.
• 11 Hoyer L. W. 1972; Immunologic studies of antihemophilic factor (AHF, factor VIII). III. Comparative binding properties of human and rabbit anti AHF. Blood 39: 481.
• 12 Kernoff P. B. A. 1973; Affinity of factor VIII clotting activity for antigen detectable immunologically. Nature (New Biology) 244: 148.
• 13 Laurell C-B. 1966; Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Analytical Biochemistry 15: 45.
• 14 Legaz M. E, Schmer G, Counts R. B, Davie E. W. 1973; Isolation and characterisation of human factor VIII (antihemophilic factor). Journal of Biological Chemistry 248: 3946.
• 15 Marchesi S. L, Shulman N. R, Gralnick H. R. 1970; Characterisation of human factor VIII (Abs). Blood 36: 833.
• 16 Owen W. G, Wagner R. H. 1972; Antihemophilic factor: separation of an active fragment following dissociation by salts or detergents. Thrombosis et Diathesis Haemorrhagica 27: 502.
• 17 Pool J. G, Robinson J. 1959; Assay of plasma anti-haemophilic globulin (AHG). British Journal of Haematology 5: 17.
• 18 Prentice C. R. M, Forbes C. D, Smith S. M. 1972; Rise in factor VIII after exercise and adrenalin infusion measured by immunological and biological techniques. Thrombosis Research 1: 493.
• 19 Rick M. E, Hoyer L. W. 1973; Immunologic studies on antihemophilic factor (AHF, factor VIII). V. Immunologic properties of AHF subunits produced by salt dissociation. Blood 42: 737.
• 20 Shearn S. A. M, Giddings J. C, Peake I. R, Bloom A. L. 1974; A comparison of five different rabbit antisera to factor VIII and the demonstration of a factor VIII related antigen in normal and von Willebrand’s disease platelets. Thrombosis Research 5: 585.
• 21 Weiss H. J, Hoyer L. W. 1973; von Willebrand factor: dissociation from antihemophilic factor procoagulant activity. Science 182: 1149.
• 22 Weiss H. J, Phillips L. L, Rosner W. 1972; Separation of subunits of antihemophilic factor (AHF) by agarose gel chromatography. Thrombosis et Diathesis Haemorrhagica 27: 212.
• 23 Zimmerman T. S, Edgington T. S. 1973; Factor VIII coagulant activity and factor VHI-like antigen: independent molecular entities. Journal of Experimental Medicine 138: 1015.
• 24 Zimmerman T. S, Ratnoff O. D, Littell A. S. 1971; Detection of carriers of classic hemophilia using an immunologic assay for antihemophilic factor (factor VIII). Journal of Clinical Investigation 50: 255.
• 25 Zimmerman T. S, Ratnoff O. D, Powell A. E. 1971; Immunologic differentiation of classic hemophilia (factor VIII deficiency) and von Willebrand’s disease. Journal of Clinical Investigation 50: 244.